Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Copaxone clinical trials
9 selected ClinicalTrials.gov records carrying the official matched intervention Copaxone (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
9 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 25 selected PubMed records and 11 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT00176592
PeptideScanner retained ClinicalTrials.gov record NCT00176592 at 2026-11-16T17:42:50.457Z. Its registry update date was 2021-11-16, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- November 16, 2021
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00239993
PeptideScanner retained ClinicalTrials.gov record NCT00239993 at 2026-11-16T17:42:50.457Z. Its registry update date was 2017-02-06, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- February 6, 2017
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00451204
PeptideScanner retained ClinicalTrials.gov record NCT00451204 at 2026-11-16T17:42:50.457Z. Its registry update date was 2016-06-16, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- June 16, 2016
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Glatiramer acetate · 2021-12-09
ClinicalTrials.gov record NCT01067521
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2021-11-16
ClinicalTrials.gov record NCT00176592
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2021-03-19
ClinicalTrials.gov record NCT00937157
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2018-11-05
ClinicalTrials.gov record NCT02153723
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2018-06-08
ClinicalTrials.gov record NCT01569451
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2018-02-06
ClinicalTrials.gov record NCT00856635
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2017-02-06
ClinicalTrials.gov record NCT00239993
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2016-06-16
ClinicalTrials.gov record NCT00451204
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2014-08-08
ClinicalTrials.gov record NCT01534182
Completed at the retained observation.
Open attributed record →